...比较分析 发心肌梗死、靶病变血运重建(target lesionrevascularization,TLR)、靶血管血运重建(target vessel revascularization,TVR)和支架内再狭窄。
基于16个网页-相关网页
当然,这些研究均一致证明,DES组患者靶血管血运重建(target vascular reconstruction,TVR)或靶病变血运重建(target lesion reconstruction,TLR)或再狭窄发生率低...
基于4个网页-相关网页
或紧急靶血管血运重建 UTVR
以及靶血管血运重建 target vessel revascularization ; TVR
和靶血管血运重建 Target Vessel Revascularization ; TVR
者靶血管血运重建 target vascular reconstruction
组患者靶血管血运重建 target vascular reconstruction
靶血管再次血运重建 TVR ; target vessel revascularization
随访至术后6个月,观察两组主要心血管事件发生率(死亡、非致死性心梗、靶血管血运重建术、新发心功能衰竭)。
Main Adverse Cardiac Events: At 6 month follow-up, there didn't exist statistics difference in the incidence of death, non-fatal MI and TVR between two groups.
主要终点为主要不良心血管事件(MACE),定义为死亡,心肌梗塞(MI),休克和靶血管血运重建(TVR)。
The primary end point used was major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), stroke and target vessel revascularization (TVR).
30天和一年的住院期间,其主要结局是缓慢流动/无复流现象(SF-NR)的发生,临床终点包括死亡、心肌梗死(MI)、靶病变血管血运重建术(TVR)和主要心脏不良事件(MACE)。
The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.
应用推荐